Member Info for MRK2020

The observations made during the Clinical study did not show any adverse events.
This is the big bit for me. Of this cohort you would have expected some deaths in the group.

Hi Chester and all,
I'll stick too...at .70 although much more confident of that being low end.
all best
MRK2020

Back at start of December I cautioned that we may not hear from bank straight away as meetings are rarely an end result in own right.. i.e letter to follow. This always made sense to me.. , and then you are in to time frames out of Vast control.
Obviously we expected to have heard because that was what we were led to believe, but that's a different matter.

Happy new year and good health to all. Get well soon chill.

We shall hear re finance soon enough. If all is well, huge upside from here. Even if doesn't come off we have a decent amount of cash to settle debts and move forwards.
That's my positive spin for the new year. Happy new year one and all.

Just one recommendation from me. TRX. They make regenerative medical products. Huge international market, and board are quietly delivering on all aspects while 4 iis have bought in heavily in past 6 months . Good message board also... Hardman report.. Link below.. would be first port of call. Plus posts of Chester on the messageboard.. Nb his posts kept me in ggp earlier this year. Sales Update due
January.https://www.hardmanandco.com/research/corporate-research/funded-through-to-profitability/
Usual caveats.
Meanwhile.. Cmon AP.. How about some good news for us tomorrow

Antharry.. Hope you are here in six months and hope I am too...As that status would mean a major positive transformation has taken place and we have ourselves a debt free profitable miner with fantastic prospects, having made huge strides in the past 18 months.
The shame of it all is that this should have been the expectation. Now I'm in the infamous hope camp lol. Should be an interesting next few weeks.

Further to my post l, the EUA link from Sample, includes the relevant sentences below vis a vis EUA minimum data.

'An EUA request for a COVID-19 vaccine can be submitted to FDA based on a final analysis of a phase 3 clinical efficacy trial or an interim analysis of such trial, i.e., an analysis performed before the planned end of the trial once the data have met the pre-specified success criteria for the study’s primary efficacy endpoint.'

The board have said that moving to P3 would be rapid and if positive they may use some of the recent fund raise to prioritise and expedite. It would be good to get details of a plan ASAP in January. I would like to think that government support would be available. This was asked in th recent investor chat and I believe they said they would look into the possibilities. I find it surprising that the sng treatment is not available yet given the desperate need for treatments. What we can guarantee however, is that positive Brazil results will prompt a flurry of activity and interest, and rightly so. Fingers crossed

The next step will have to be a phase 3 trial which the board have suggested would be multi site. UK and USA probably to reflect the subsequent approvals they would seek... E. G. EUA. So yes a larger cohort. They only had 60 cases I believe in the Santos trial, so it's some way from EUA yet. Nb. The trial has relevance not only to Covid but to other conditions resulting in respiratory attack.

Roaring 20s would be good from a couple of perspectives. Christmas blessings all round

I think I see another late reported trade... A suspected buy of over £500k from yesterday. Feels like a hugely significant day yesterday in terms of volume and II involvement.

I think I see another late reported trade... A suspected buy of over £500k from yesterday. Feels like a hugely significant day yesterday in terms of volume and II involvement.

Lots of activity indeed. Spreadex were below 3% but will be interesting to see if any holding notifications next week. Hopefully a path cleared for an overdue and sustained rise.

It's true. And that is why the 'Hope' subject heading was always spot on :-)
Anyhow, hopefully some unambiguously good news shortly/imminently

So should be a buy.. yet no impact on SP as I write... but encouraging sign.
Thanks to Mafuta re Caitlin contact. I have emailed.
all best for Christmas and new year. Stay safe all

Parked some cash in the Shed yesterday after keeping an eye on for months. In line with the Hard man report this month, can only see this going higher. With decent dividends too this seems a massively overlooked stock to me especially with the current acquisitions going on. I look forward to next set of results with confidence. Gla

This feels like Fomo and people taking positions in case of positive covid treatment news. While positive news would of course be great... Not least because we might already have saved lives, there would still be some way to go to commercialisation. Frankly though it's nice to be in a share where that is my secondary concern.
A positive result would also be fab news for use in other respiratory failure events presenting similar conditions. Gla

A little more proactivity would help.. Last twitter update January. Website currently blocked by my browser as unsafe.. Hmm. Not great is it. No interviews with new chief executive. No news from US expansion. Frustrating attitude. Is there an investor relations contacy at the company. I will make contact if someone can identify. Anyhow... A nice January update would be welcome.
I think this company has great products and prospects. but given they are in sales, they need to be more vocal

been off the bbs for a few weeks...what did I miss lol.
I was planning to use the 'Hope' subject thread...Don't tell me even that's gone now ha.
I might just come back in a couple more weeks. As long as we are still digging up a load of copper we should be ok in the longer run.

Personally I too suspect an II selling down..Hopefully Spreadex clearing out as expected,. Under 3% hence may not be a TR1.